Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More
Shares of social commerce platform Pinterest (NYSE: PINS)
jumped 4.1% in the morning session after a broad rally in the technology sector, sparked by stellar earnings reports from industry giants Meta and Microsoft.
Robinhood Markets, Inc. (NASDAQ: HOOD) has delivered a stunning performance in its second quarter of 2025, reporting financial results that significantly exceeded analyst expectations. The fintech pioneer, once primarily known for commission-free stock trading, showcased robust growth across diversified revenue streams, particularly in cryptocurrency and options trading, alongside a surge
Citi anticipates CoreWeave to benefit from a notable growth uptick starting in 2026, with the optimism hinging on the company’s ability to scale contracts and capitalize on a strengthening market for AI infrastructure.
Shares of fast-food chain Wingstop (NASDAQ:WING)
jumped 23.9% in the morning session after the company reported better-than-expected second-quarter earnings and raised its full-year guidance for global store expansion.
AI stocks Palantir and CoreWeave have rocketed higher this year, but certain analysts expect shareholders to sustain major losses in the coming months.
The software giant is widely expected to report earnings per share of $3.38 and revenue of $73.83 billion for the fourth quarter of the fiscal year 2025, according to the Fiscal.ai-compiled consensus.
Shares of health coverage company Centene (NYSE:CNC)
fell 3.3% in the morning session after JPMorgan cut its price target on the managed care company to $30 from $48. This move by JPMorgan followed Centene's recent second-quarter earnings report, where the company posted a loss of $0.16 per share, missing analyst estimates. The poor results were largely attributed to a significant reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, an issue that first came to light when Centene withdrew its full-year guidance on July 1st. The company's performance prompted a series of downgrades from Wall Street, with firms like UBS, Wells Fargo, and Morgan Stanley also cutting their price targets, signaling widespread concern over the company's ability to restore its earnings trajectory.
